420 related articles for article (PubMed ID: 32704031)
1. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Thompson ED; Roberts NJ; Wood LD; Eshleman JR; Goggins MG; Kern SE; Klein AP; Hruban RH
Mod Pathol; 2020 Dec; 33(12):2544-2563. PubMed ID: 32704031
[TBL] [Abstract][Full Text] [Related]
2. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
3. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
[TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Kupfer SS; Gupta S; Weitzel JN; Samadder J
Gastroenterology; 2020 Aug; 159(2):760-764. PubMed ID: 32335146
[No Abstract] [Full Text] [Related]
5. Genetics of Familial and Sporadic Pancreatic Cancer.
Wood LD; Yurgelun MB; Goggins MG
Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic biomarkers: could they be the answer?
Lamarca A; Feliu J
World J Gastroenterol; 2014 Jun; 20(24):7819-29. PubMed ID: 24976720
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
8. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Ho J; Li X; Zhang L; Liang Y; Hu W; Yau JCW; Chan H; Gin T; Chan MTV; Tse G; Wu WKK
Semin Cancer Biol; 2019 Apr; 55():70-77. PubMed ID: 29705685
[TBL] [Abstract][Full Text] [Related]
9. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 Expression in Pancreas Adenocarcinoma Tumor Microenvironment Via Endoscopic Ultrasound Fine Needle Biopsy Is Feasible and May Reveal a Therapeutic Target.
Gleeson FC; Levy MJ; Jackson RA; Murphy SJ; Halling KC; Kipp BR; Graham RP; Zhang L
Pancreas; 2020; 49(10):e98-e99. PubMed ID: 33122534
[No Abstract] [Full Text] [Related]
11. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Kenner BJ; Chari ST; Cleeter DF; Go VL
Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
[TBL] [Abstract][Full Text] [Related]
13. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract][Full Text] [Related]
16. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
Chandana S; Mahadevan D
Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
[TBL] [Abstract][Full Text] [Related]
17. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
[TBL] [Abstract][Full Text] [Related]
19. Can we move towards personalised pancreatic cancer therapy?
Jamieson NB; Chang DK; Grimmond SM; Biankin AV
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):335-8. PubMed ID: 24702631
[No Abstract] [Full Text] [Related]
20. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Hu Y; Chen Y
Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
